Inhibition of yeast (1,3)-beta-glucan synthase by phospholipase A2 and its reaction products.
Fungal (1,3)-beta-glucan synthases are sensitive to a wide range of lipophilic inhibitors and it has been proposed that enzyme activity is highly sensitive to perturbations of the membrane environment. Yeast membranes were exposed to phospholipases and various lipophilic compounds, and the resultant effects on glucan synthase activity were ascertained. Glucan synthase from Saccharomyces cerevisiae was rapidly inactivated by phospholipase A2 (PLA2), and to a lesser extent by phospholipase C. Inactivation was time and dose-dependent and was protected against by EDTA and fatty-acid binding proteins (bovine and human serum albumins). Albumins also partially protected against inhibition by papulacandin B. PLA2 reaction products were structurally characterized and it was shown that fatty acids and lysophospholipids were the inhibitory moieties, with no novel inhibitory compounds apparent. Glucan synthase was inhibited by a range of fatty acids, monoglycerides and lysophospholipids. Inhibition by fatty acids was non-competitive, and progressive binding of [14C]oleic acid correlated with activity loss. Fluorescence anisotropy studies using diphenylhexatriene (DPH) confirm that fatty acids increase membrane fluidity. These results are consistent with proposals suggesting that glucan synthase inhibition is due in part to non-specific detergent-like disruption of the membrane environment, in addition to direct interactions of lipophilic inhibitors with specific target sites on the enzyme complex.
Ko
Y T
YT
Department of Food Science, Rutgers University, Cook College, New Jersey Agricultural Experiment Station, New Brunswick 08903-0231.
Frost
D J
DJ
Ho
C T
CT
Ludescher
R D
RD
Wasserman
B P
BP
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D005227:Fatty Acids / Q000494:pharmacology; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors*; D007700:Kinetics; D008560:Membrane Fluidity / Q000187:drug effects; D008565:Membrane Proteins; D010741:Phospholipases A / Q000737:chemistry / Q000494:pharmacology*; D054467:Phospholipases A2; D012441:Saccharomyces cerevisiae / Q000201:enzymology*; D029702:Schizosaccharomyces pombe Proteins; D012709:Serum Albumin
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D008565:Membrane Proteins; D029702:Schizosaccharomyces pombe Proteins; D012709:Serum Albumin; C020789:papulacandin B; D005964:Glucosyltransferases; C020570:1,3-beta-glucan synthase; D010741:Phospholipases A; D054467:Phospholipases A2